This HTML5 document contains 124 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74590600
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en marzu de 1999 scientific article published on 01 March 1999 наукова стаття, опублікована в березні 1999 im März 1999 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q74590600-D409633F-1368-4CC7-A57F-71224C2A004B
wdt:P577
1999-03-01T00:00:00Z
p:P2860
wds:Q74590600-56CED3F3-62A2-4FB5-AF89-BB9A8B9F723F wds:Q74590600-5A686147-692F-46EA-8C05-B53606845AD2 wds:Q74590600-0E90FD6B-9F31-4405-B0E3-8EB3E77CCF25 wds:Q74590600-1C48857E-0AC0-4AAF-BFE1-7745E43DC00E wds:Q74590600-1C78928B-DB0A-431D-B049-B294A9DF4E48 wds:Q74590600-211D6C9D-E008-468A-9CEA-E6BFC19AA899 wds:Q74590600-302B67FA-70C9-4A3E-A04D-B0FCC7DF0C8F wds:Q74590600-3312044D-3FE0-44D1-9529-9A566256933A wds:Q74590600-860960AB-A794-48F4-BB45-ADDECFC2E421 wds:Q74590600-86B5F78C-F8D1-4471-B9D6-DE7E9357CE7C wds:Q74590600-924C9563-3957-4E5F-A190-3DF220CCFED0 wds:Q74590600-9851B793-2D37-48F3-A13A-7DBED9E62140 wds:Q74590600-9AAC2D23-496A-4812-8937-239CE925AC59 wds:Q74590600-AD961D44-4EAA-4135-90E1-446FBC521F99 wds:Q74590600-618AEDA6-ED80-4461-AB27-EAEAAA252FD6 wds:Q74590600-6284BC9A-8BFA-4181-B262-316EE8FBD9F4 wds:Q74590600-7C8542A9-2491-4B8B-AC39-51E2404302C8 wds:Q74590600-84B672F5-3008-45CA-BE67-F0D20A296D74 wds:Q74590600-086E891D-E7A3-4BA8-859B-774DA12FD782 wds:Q74590600-D48A61D2-2809-4CCD-A69A-6E85131DFBF5 wds:Q74590600-D5FECDCA-9E23-403D-B4A8-6E3B17DF8323 wds:Q74590600-D850180A-5ADD-4CE2-909C-EF6AFE8AF550 wds:Q74590600-DD9554DC-E211-49C8-84E6-3EEC27A487F5 wds:Q74590600-E14CA215-AB3B-40F2-BEB1-B4F1CEE88A9D wds:Q74590600-E3424338-3DE3-46D7-8B82-8B869E85DACB wds:Q74590600-BB63B6EF-0BFB-42BB-9FCF-ABE6CADE9F01 wds:Q74590600-C0D11F2E-35D2-4D50-85E0-87F3B0856313 wds:Q74590600-C55F6EF3-7792-48D4-8D13-FBE79AC7979B wds:Q74590600-C7E5D4E7-D531-48AB-B9A3-EADE19396BD3 wds:Q74590600-C94E1F7C-33EF-4419-8627-66679F0B5A26 wds:Q74590600-CB1BB4FC-E1F6-4AEA-9777-8CC650A7D8F0 wds:Q74590600-CC7FC191-4E9B-4187-8E72-4E40D10F3B69 wds:Q74590600-E980077F-4E92-440E-9A9B-2734EB9F2DE8 wds:Q74590600-ED3A6EA6-150D-41E0-8FE8-04566EE0C450 wds:Q74590600-FE9A1937-FAE6-4824-9583-4AF17C05575E wds:Q74590600-FFD0BBA3-94E3-440D-879F-4754D3A0F84B wds:Q74590600-4075DFB2-3F50-484A-8D0D-37A50769E5CF wds:Q74590600-42411F4C-3C6D-4E64-9FFA-5878EE7D1EE7
wdt:P2860
wd:Q41197357 wd:Q43431488 wd:Q67522229 wd:Q52701671 wd:Q71723661 wd:Q42594253 wd:Q34241868 wd:Q72229770 wd:Q71131758 wd:Q35181695 wd:Q72957651 wd:Q67522227 wd:Q67525282 wd:Q36274606 wd:Q67522235 wd:Q71089909 wd:Q71927119 wd:Q72678975 wd:Q70708524 wd:Q67525284 wd:Q69109737 wd:Q71459994 wd:Q72609110 wd:Q69914430 wd:Q41453348 wd:Q34554363 wd:Q33775495 wd:Q53789780 wd:Q39513510 wd:Q44996590 wd:Q33604886 wd:Q72232753 wd:Q33821265 wd:Q53723061 wd:Q34667831 wd:Q39491549 wd:Q71810390 wd:Q40541194
p:P2093
wds:Q74590600-8F398442-CB04-417A-9CA8-5B2580030953 wds:Q74590600-6CC567C9-57C9-4059-855B-749E559752CE wds:Q74590600-5F8826B3-97A3-43BC-9508-D3CB78813C5F wds:Q74590600-4FBB81EC-42CA-4F9E-A207-59DD2F41F0A7 wds:Q74590600-27B97D1D-AD2B-4E40-9BA6-36596EF6A76A wds:Q74590600-E5A66BBD-0B4B-4B04-A0D0-ED1772E19FEC wds:Q74590600-CA7714B8-81CC-423D-A2A6-90D977A964E1
wdt:P2093
R Brambilla G Della Cioppa D Stubbing J M FitzGerald M D Till K R Chapman M S Fairbarn
rdfs:label
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
skos:prefLabel
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
schema:name
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
p:P1476
wds:Q74590600-0D02FC5D-8201-45A5-B8EE-78AF1867D9EF
wdt:P1476
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
p:P304
wds:Q74590600-4A443768-4103-40D2-8B07-F46DA0ED7690
wdt:P304
427-435
p:P31
wds:Q74590600-4F8DA314-760A-405E-81CE-5041EB54FA12
wdt:P31
wd:Q13442814
p:P921
wds:Q74590600-0C23A7B3-EFCF-4D98-8AD2-054527472D80
wdt:P921
wd:Q35869
p:P698
wds:Q74590600-03D190C7-F7EA-442F-9174-67EC0104C246
wdtn:P698
n10:10069876
wdt:P698
10069876
p:P1433
wds:Q74590600-7CA2C30D-D985-4866-B75B-831BC91295A9
wdt:P1433
wd:Q7743550
p:P433
wds:Q74590600-603AB844-82B0-471B-A8FA-B7A2465383CF
p:P478
wds:Q74590600-416A318F-3379-40F9-B4AA-28A69F9189CA
wdt:P433
3 Pt 1
wdt:P478
103
p:P356
wds:Q74590600-86737809-E8CB-4C87-A2C0-207351B4D9D1
wdtn:P356
n11:S0091-6749(99)70467-7
wdt:P356
10.1016/S0091-6749(99)70467-7